Security Snapshot

Outset Medical, Inc. - Common Stock, par value $0.001 per share (OM) Institutional Ownership

CUSIP: 690145107

13F Institutional Holders and Ownership History from Q3 2020 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

2

Shares (Excl. Options)

99,390

Price

$11.10

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
-97,971
Value change
-$361,014
Number of holders
2
Issuer context Names, identifiers, and filing context for this profile. 2 identity fields
Shares outstanding
18,527,213
SEC-reported price per share
$11.10
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • OM - Outset Medical, Inc. - Common Stock, par value $0.001 per share is tracked under CUSIP 690145107.
  • 2 institutions reported positions in Q1 2026.
  • 6 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 3 to 2 between Q4 2025 and Q1 2026.
  • SEC-reported value moved from $738,306 to $389,039.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 2 institutions filings for Q1 2026.

Open SEC evidence

Security key

690145107

Latest holder period

Q1 2026

13F holders

2

13D/G owners

6

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
6
Security
OM
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Durable Capital Partners LP 9.9% $154,630,808 26,609,101 Durable Capital Partners LP 03 Jan 2025
PERCEPTIVE ADVISORS LLC 9.5% $32,688,000 5,625,000 Perceptive Advisors LLC 08 Jan 2025
FMR LLC 7% $21,334,153 3,671,213 FMR LLC 31 Dec 2024
BML Investment Partners, L.P. 14% +15% $27,981,280 +$3,586,915 2,519,701 +15% BML Investment Partners, L.P. 15 May 2026
PFM Health Sciences, LP 2.9% -72% $1,969,253 -$90,780,747 530,796 -98% PFM Health Sciences, LP 31 Dec 2025
Woodline Partners LP 1.6% $5,372,097 292,437 Woodline Partners LP 31 Mar 2026

As of 31 Mar 2026, 2 institutional investors reported holding 99,390 shares of Outset Medical, Inc. - Common Stock, par value $0.001 per share (OM). This represents 0.54% of the company’s total 18,527,213 outstanding shares.

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
23
Latest
Q1 2026
Rows shown
1-23 of 23
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 99,390 $389,039 -$361,014 $11.10 2
2025 Q4 197,361 $738,306 +$79,533 $3.71 3
2025 Q3 176,842 $2,498,949 +$2,006,565 $14.12 3
2025 Q2 34,734 $667,997 +$195,729 $21.73 2
2025 Q1 24,600 $271,908 -$26,758,605 $5.81 2
2024 Q4 21,051,997 $23,361,826 -$3,640,595 $1.11 73
2024 Q3 26,056,953 $17,615,217 -$39,745,792 $0.68 76
2024 Q2 48,587,379 $187,047,220 -$5,223,928 $3.85 118
2024 Q1 50,439,872 $111,971,022 -$20,061,860 $2.22 109
2023 Q4 53,020,613 $286,839,451 -$59,832,469 $5.41 137
2023 Q3 53,632,748 $583,471,975 -$2,257,141 $10.88 150
2023 Q2 52,992,751 $1,158,352,799 +$26,029,052 $21.87 153
2023 Q1 52,028,882 $957,169,691 +$47,145,083 $18.40 159
2022 Q4 49,004,926 $1,265,397,709 +$1,900,384 $25.82 147
2022 Q3 47,753,322 $759,751,328 -$60,798,422 $15.93 131
2022 Q2 48,521,355 $721,230,096 -$163,983,262 $14.86 143
2022 Q1 51,296,045 $2,328,323,118 +$123,798,869 $45.40 147
2021 Q4 48,556,337 $2,237,798,401 -$207,141,965 $46.09 153
2021 Q3 50,674,901 $2,506,125,357 +$215,826,366 $49.44 138
2021 Q2 46,277,397 $2,312,251,576 +$391,010,353 $49.98 126
2021 Q1 38,393,386 $2,088,213,344 +$50,139,442 $54.39 109
2020 Q4 37,414,688 $2,088,176,575 +$69,477,743 $56.84 110
2020 Q3 36,169,665 $1,762,305,350 +$1,762,305,350 $50.00 85
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .